Release Date: 15/06/16 12:47 Summary: ePAT Signs MOU with UK Insurance Counter-Fraud Group-MNQ.AX Price Sensitive: Yes Download Document 600.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%